You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MGMT methylated

Showing 1 - 25 of 178
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

Newly Diagnosed Glioblastoma Trial ([177Lu]Lu-NeoB, [68Ga]Ga-NeoB, Temozolomide)

Not yet recruiting
  • Newly Diagnosed Glioblastoma
  • (no location specified)
Feb 13, 2023

Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Multipeptide plus XS15
  • Tübingen, BW, Germany
    University Hospital Tübingen
May 9, 2022

First Progression of MGMT Promoter-methylated Glioblastoma Trial in Bellinzona, Zürich (Lomustine, Romiplostim)

Recruiting
  • First Progression of MGMT Promoter-methylated Glioblastoma
  • Barcelona, Spain
  • +4 more
Nov 16, 2022

Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)

Recruiting
  • Adenocarcinoma - GEJ
  • Cancer of Esophagus
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Oct 6, 2021

MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)

Not yet recruiting
  • MGMT-Methylated Glioblastoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • (no location specified)
Jun 28, 2022

Metastatic Colorectal Cancer Trial in Milan (Capecitabine, Temozolomide, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Milan, Mi, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Sep 3, 2021

Malignant Glioma of Brain Trial in Chicago (Acetazolamide, Temozolomide)

Recruiting
  • Malignant Glioma of Brain
  • Chicago, Illinois
    University of Chicago Medical Center
Apr 1, 2022

Grade IV Astrocytoma, Glioblastoma Trial in France (Temozolomide, folinic acid at pharmacological dose is the escalated drug,

Terminated
  • Grade IV Astrocytoma
  • Glioblastoma
  • Angers, France
  • +3 more
May 20, 2021

Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023

Glioblastoma, Brain Tumor, Cannabis Trial in United Kingdom (Sativex, Temozolomide, Sativex-matched )

Not yet recruiting
  • Glioblastoma
  • +3 more
  • Belfast, United Kingdom
  • +14 more
Nov 29, 2022

Glioblastoma, Gliosarcoma Trial in United States (drug, radiation, other)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Little Rock, Arkansas
  • +119 more
Aug 11, 2022

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Glioma, Malignant Trial in United States (biological, drug, radiation, other)

Active, not recruiting
  • Glioma, Malignant
  • AdV-tk
  • +5 more
  • Los Angeles, California
  • +7 more
Jan 30, 2023

Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)

Recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Colorectal Cancer Trial (Irinotecan, Temozolomide)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 1, 2022

Glioblastoma Trial (Azeliragon)

Not yet recruiting
  • Glioblastoma
  • (no location specified)
Aug 3, 2023

Colorectal Cancer, Triple Negative Breast Cancer, Pancreatic Cancer Trial in Denver, Miami, Houston (Toca 511, Toca FC)

Terminated
  • Colorectal Cancer
  • +11 more
  • Toca 511
  • Toca FC
  • Denver, Colorado
  • +2 more
Feb 5, 2020

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Glioblastoma Trial in United States (biological, radiation, drug)

Active, not recruiting
  • Glioblastoma
  • INO-5401
  • +4 more
  • Duarte, California
  • +20 more
Aug 8, 2022

Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

Recruiting
  • Colorectal Neoplasms
  • Microsatellite Instability
  • temozolomide (induction),
  • pembrolizumab (treatment)
  • Milano, Italy
  • +3 more
Sep 28, 2022

Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)

Recruiting
  • Rectal Cancer
  • External-beam radiation
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jan 25, 2022